(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LENTIG

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LENTIG

ST13

US500000079232608

Class

5

Filing

79232608

Registration

5603947

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

01/31/2026

Trademark type

Word

Nice classes

5

Filing date

03/15/2018

Registration date

11/13/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/30/2025

Last transaction

01/31/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

US

Examiner

KUYKENDALL, LYNDSEY

Law office

N60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Genetix Biotherapeutics, Inc.
bluebird bio, Inc.
Bluebird Bio (UK) Ltd.

Representatives

John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of genetic diseases

Publications

History of USPTO decisions and trademark events.

34 publications found

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/30/2026

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/18/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/13/2025

C71T

CANCELLED SECTION 71

05/30/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

09/13/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/23/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/13/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/26/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/15/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/18/2019

CHLD

CHANGE OF OWNER RECEIVED FROM IB

06/13/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/16/2019

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/22/2019

FIMP

FINAL DISPOSITION PROCESSED

02/22/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/13/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

11/13/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/28/2018

PUBO

PUBLISHED FOR OPPOSITION

08/28/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/08/2018

RFNT

REFUSAL PROCESSED BY IB

07/27/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/19/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/18/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/18/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/18/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/18/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/11/2018

RFRR

REFUSAL PROCESSED BY MPU

07/11/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/27/2018

CNRT

NON-FINAL ACTION WRITTEN

06/26/2018

DOCK

ASSIGNED TO EXAMINER

06/25/2018

MAFR

APPLICATION FILING RECEIPT MAILED

06/02/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/29/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/24/2018

Continuous trademark protection

Get notified about every new filing that threatens LENTIG or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.